BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 2012
View Archived Issues
New PAK-4 inhibitor under development to treat gastric cancers
Read More
Scientists discover novel neurotrophic drug to treat cognitive decline
Read More
Findings presented from two phase III trials of Lu-AA-21004 in GAD
Read More
Kinetin shows promise to treat familial dysautonomia
Read More
Astellas Pharma presents new drug for treatment of transplant rejection
Read More
Toray divulges new inhibitors of 11-beta-HSD1
Read More
New camptothecin derivatives designed in Spain
Read More
IntraCellular Therapies claims novel phosphodiesterase 1B inhibitors
Read More
Novel phosphodiesterase inhibitors disclosed
Read More
New monoglyceride lipase inhibitors prepared by Sanofi
Read More
Syndax Pharmaceuticals designs new azacitidine prodrugs
Read More
Roche presents novel drugs for Parkinson's disease
Read More
FDA advisory committee to review Xgeva sBLA
Read More
Apricus Biosciences finalizes acquisition
Read More
BG Medicine files application for second cardiovascular diagnostic test
Read More
Marshall Edwards raises funds to advance lead oncology candidates
Read More
Opko Health completes acquisition
Read More
Symmetry Medical acquires surgical instruments business
Read More
Amgen moves AMG-172 to clinic
Read More
MethylGene recruiting participants in phase II MGCD-290 study
Read More
Gene therapy for wet AMD enters phase I/II testing
Read More
Clinical trial application submitted in Russia for AT-001
Read More
Clinical development ZP-1846 advances
Read More
FDA expands indication of Prevnar 13
Read More
Prima BioMed provides update on preclinical testing of Cripto-1 immunotherapy
Read More
